Stay updated on Nivolumab + Brentuximab Vedotin in Hodgkin Lymphoma Clinical Trial

Sign up to get notified when there's something new on the Nivolumab + Brentuximab Vedotin in Hodgkin Lymphoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab + Brentuximab Vedotin in Hodgkin Lymphoma Clinical Trial page

  1. Check
    2 days ago
    Change Detected
    Summary
    The page's revision label updated from v3.6.5 to v3.6.6, indicating a newer version of the page without changing the trial details.
    Difference
    0.0%
    Check dated 2026-09-03T18:41:12.000Z thumbnail image
  2. Check
    9 days ago
    Change Detected
    Summary
    The added text '2017 ( U.S. NIH Grant/Contract )' appears in the Study ID Numbers area, indicating NIH funding for the trial.
    Difference
    0.0%
    Check dated 2026-08-27T17:26:38.000Z thumbnail image
  3. Check
    17 days ago
    No Change Detected
  4. Check
    24 days ago
    Change Detected
    Summary
    The page revision tag was updated from v3.6.4 to v3.6.5. This indicates a new revision of the page content.
    Difference
    0.0%
    Check dated 2026-08-13T10:11:56.000Z thumbnail image
  5. Check
    45 days ago
    Change Detected
    Summary
    The page now shows Revision: v3.6.4, replacing the previous v3.6.3 label and indicating an updated version of the content.
    Difference
    0.0%
    Check dated 2026-07-23T05:43:27.000Z thumbnail image
  6. Check
    67 days ago
    Change Detected
    Summary
    Revision: v3.6.3 is now displayed, replacing v3.6.0. This indicates a minor update to the page's revision history/documentation rather than substantive content changes.
    Difference
    0.0%
    Check dated 2026-07-01T12:27:41.000Z thumbnail image
  7. Check
    82 days ago
    Change Detected
    Summary
    The page now includes new guidance sections (How to Read a Study Record, Common Questions, How to Join a Study) and an updated Intervention/Treatment label, and it notes that recruitment is closed ('No longer looking for participants') with a revision update to v3.6.0.
    Difference
    0.4%
    Check dated 2026-06-16T05:33:43.000Z thumbnail image

Stay in the know with updates to Nivolumab + Brentuximab Vedotin in Hodgkin Lymphoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab + Brentuximab Vedotin in Hodgkin Lymphoma Clinical Trial page.